Total Funding
42
1
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3074747
InDanio Bioscience Inc is a privately-held in vivo drug discovery company.
Henry Krause: Founder
About the Company
InDanio Bioscience Inc., is a privately-held in vivo drug discovery company dedicated to developing New Chemical Entities (NCEs) targeting the pharmaceutically-important Nuclear Receptor (NR) protein families.
Their proprietary, Ligand Trap system, which includes 48 transgenic zebrafish lines, each singularly expressing one of the 48 human Nuclear
Receptors, allows simultaneous assessment of drug delivery, stability, specificity, tissue-selectivity and toxicity. Selective, highest-value target lines are being used to identify, extract and characterize new hormonal regulators, as well as to identify new tissue-selective drugs, co-factors and mechanisms of action for each Nuclear Receptor.
